Shilpa Medicare has received approval from USFDA for Varenicline Tablets, 0.5 and 1 mg. The total US market for this product is around 203 M USD. Shilpa's product has been approved as a generic ...

Varenicline is available in 0.5- and 1-mg tablets. The labeling information recommends adjusting the dosage from 0.5 mg once daily for days 1-3 to 0.5 mg twice daily for days 4-7, with a final ...

Varenicline is a nicotinic acetylcholine receptor and has some of the highest success rates among smoking cessation ...

Karnataka: Shilpa Medicare Limited has received approval from the US Food and Drugs Administration (USFDA) for Varenicline ...

Background It is important to know the comparative effectiveness of varenicline and nicotine replacement therapy (NRT) for smoking cessation when prescribed under routine circumstances and in the ...

The company focuses on developing effective formulations in the form of tablets, capsules ... Partial Nicotinic Receptor Agonist: Varenicline binds to a4b2 nicotinic receptors, partially ...